Merck Serono, a division of German's Merck KGaA, has announced a new five-year clinical development agreement with Quintiles. This strategic collaboration is the first-of-its-kind between a ...

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

The Accelerated Cure Project for Multiple Sclerosis launched a new website to better support caregivers of people with MS.

In Europe and Canada, where the drug is marketed by Geneva-based Merck Serono and Serono of Mississauga, Ontario, respectively, regulators have taken Raptiva off the market, stating that the ...